Literature DB >> 25548085

The gut sensor as regulator of body weight.

Thomas Reinehr1, Christian L Roth.   

Abstract

The gastrointestinal (GI) tract comprises a large endocrine organ that regulates not only nutrient sensing and metabolising but also satiety and energy homeostasis. More than 20 hormones secreted from the stomach, intestine, and pancreas as well as signaling mediators of the gut microbiome are involved in this process. A better understanding of how related pathways affect body weight and food intake will help us to find new strategies and drugs to treat obesity. For example, weight loss secondary to lifestyle intervention is often accompanied by unfavorable changes in multiple GI hormones, which may cause difficulties in maintaining a lower body weight status. Conversely, bariatric surgery favorably changes the hormone profile to support improved satiety and metabolic function. This partially explains stronger sustained body weight reduction resulting in better long-term results of improved metabolic functions. This review focuses on GI hormones and signaling mediators of the microbiome involved in satiety regulation and energy homeostasis and summarizes their changes following weight loss. Furthermore, the potential role of GI hormones as anti-obesity drugs is discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25548085     DOI: 10.1007/s12020-014-0518-1

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  149 in total

1.  Amylin decreases meal size in rats.

Authors:  T A Lutz; N Geary; M M Szabady; E Del Prete; E Scharrer
Journal:  Physiol Behav       Date:  1995-12

2.  Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake.

Authors:  Jian V Zhang; Pei-Gen Ren; Orna Avsian-Kretchmer; Ching-Wei Luo; Rami Rauch; Cynthia Klein; Aaron J W Hsueh
Journal:  Science       Date:  2005-11-11       Impact factor: 47.728

3.  Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis.

Authors:  Aurélien Trompette; Eva S Gollwitzer; Koshika Yadava; Anke K Sichelstiel; Norbert Sprenger; Catherine Ngom-Bru; Carine Blanchard; Tobias Junt; Laurent P Nicod; Nicola L Harris; Benjamin J Marsland
Journal:  Nat Med       Date:  2014-01-05       Impact factor: 53.440

Review 4.  Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes.

Authors:  Michael A Nauck; Birgit Baller; Juris J Meier
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

5.  Peripheral oxyntomodulin reduces food intake and body weight gain in rats.

Authors:  Catherine L Dakin; Caroline J Small; Rachel L Batterham; Nicola M Neary; Mark A Cohen; Michael Patterson; Mohammad A Ghatei; Stephen R Bloom
Journal:  Endocrinology       Date:  2004-03-04       Impact factor: 4.736

6.  Effects of acute and longer-term dietary restriction on upper gut motility, hormone, appetite, and energy-intake responses to duodenal lipid in lean and obese men.

Authors:  Radhika V Seimon; Pennie Taylor; Tanya J Little; Manny Noakes; Scott Standfield; Peter M Clifton; Michael Horowitz; Christine Feinle-Bisset
Journal:  Am J Clin Nutr       Date:  2013-11-06       Impact factor: 7.045

7.  Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation.

Authors:  Leandro Soriano-Guillén; Vicente Barrios; Angel Campos-Barros; Jesús Argente
Journal:  J Pediatr       Date:  2004-01       Impact factor: 4.406

8.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.

Authors:  Kendle M Maslowski; Angelica T Vieira; Aylwin Ng; Jan Kranich; Frederic Sierro; Di Yu; Heidi C Schilter; Michael S Rolph; Fabienne Mackay; David Artis; Ramnik J Xavier; Mauro M Teixeira; Charles R Mackay
Journal:  Nature       Date:  2009-10-29       Impact factor: 49.962

9.  Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.

Authors:  K Zwirska-Korczala; S J Konturek; M Sodowski; M Wylezol; D Kuka; P Sowa; M Adamczyk-Sowa; M Kukla; A Berdowska; J F Rehfeld; W Bielanski; T Brzozowski
Journal:  J Physiol Pharmacol       Date:  2007-03       Impact factor: 3.011

10.  The effect of multidisciplinary lifestyle intervention on the pre- and postprandial plasma gut Peptide concentrations in children with obesity.

Authors:  Rimke C Vos; Hanno Pijl; Jan M Wit; Erik W van Zwet; Chris van der Bent; Euphemia C A M Houdijk
Journal:  ISRN Endocrinol       Date:  2011-06-01
View more
  9 in total

Review 1.  Gut Microbiota in Obesity and Undernutrition.

Authors:  Nicolien C de Clercq; Albert K Groen; Johannes A Romijn; Max Nieuwdorp
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

2.  The Effect of Gastric Bypass with a Distal Gastric Pouch on Glucose Tolerance and Diabetes Remission in Type 2 Diabetes Sprague-Dawley Rat Model.

Authors:  Ponnie Robertlee Dolo; Yong Shao; Chao Li; Xiaocheng Zhu; Libin Yao; Hui Wang
Journal:  Obes Surg       Date:  2019-06       Impact factor: 4.129

3.  Linoleic acid permeabilizes gastric epithelial cells by increasing connexin 43 levels in the cell membrane via a GPR40- and Akt-dependent mechanism.

Authors:  Carlos Puebla; Bruno A Cisterna; Daniela P Salas; Fernando Delgado-López; Paul D Lampe; Juan C Sáez
Journal:  Biochim Biophys Acta       Date:  2016-02-08

4.  Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague-Dawley Rat Model.

Authors:  Ponnie R Dolo; Libin Yao; Chao Li; Xiaocheng Zhu; Linsen Shi; Jason Widjaja
Journal:  Obes Surg       Date:  2018-05       Impact factor: 4.129

5.  Exclusion of the Distal Ileum Cannot Reverse the Anti-Diabetic Effects of Duodenal-Jejunal Bypass Surgery.

Authors:  Jie Chai; Guangyong Zhang; Shaozhuang Liu; Chunxiao Hu; Haifeng Han; Sanyuan Hu; Zongli Zhang
Journal:  Obes Surg       Date:  2016-02       Impact factor: 4.129

Review 6.  NIH working group report-using genomic information to guide weight management: From universal to precision treatment.

Authors:  Molly S Bray; Ruth J F Loos; Jeanne M McCaffery; Charlotte Ling; Paul W Franks; George M Weinstock; Michael P Snyder; Jason L Vassy; Tanya Agurs-Collins
Journal:  Obesity (Silver Spring)       Date:  2016-01       Impact factor: 5.002

7.  Glucagon-like peptide-2 modulates the nitrergic neurotransmission in strips from the mouse gastric fundus.

Authors:  Rachele Garella; Eglantina Idrizaj; Chiara Traini; Roberta Squecco; Maria Giuliana Vannucchi; Maria Caterina Baccari
Journal:  World J Gastroenterol       Date:  2017-10-28       Impact factor: 5.742

8.  Gastrointestinal Hormones in Healthy Adults: Reliability of Repeated Assessments and Interrelations with Eating Habits and Physical Activity.

Authors:  Silke M Wortha; Katharina A Wüsten; Veronica A Witte; Nicole Bössel; Wolfram Keßler; Antje Vogelgesang; Agnes Flöel
Journal:  Nutrients       Date:  2021-10-26       Impact factor: 5.717

9.  Impaired Brain Satiety Responses After Weight Loss in Children With Obesity.

Authors:  Christian L Roth; Susan J Melhorn; Mary Rosalynn B De Leon; Maya G Rowland; Clinton T Elfers; Alyssa Huang; Brian E Saelens; Ellen A Schur
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.